From the Journals

Frequent visits to green spaces linked to lower use of some meds


 

Evidence mounts on the benefits of nature

There is growing evidence that exposure to nature could benefit human health, especially mental and cardiovascular health, says Jochem Klompmaker, PhD, a postdoctoral researcher in the department of environmental health at the Harvard T.H. Chan School of Public Health, Boston.

Dr. Klompmaker has researched the association between exposure to green spaces and health outcomes related to neurological diseases.

In a study recently published in JAMA Network Open, and reported by this news organization, Dr. Klompmaker and his team found that among a large cohort of about 6.7 million fee-for-service Medicare beneficiaries in the United States aged 65 or older, living in areas rich with greenery, parks, and waterways was associated with fewer hospitalizations for certain neurological disorders, including Parkinson’s disease, Alzheimer’s disease, and related dementias.

Commenting on the current study, Dr. Klompmaker noted its strengths.

“A particular strength of this study is that they used data about the amount of green and blue spaces around the residential addresses of the participants, data about green space visit frequency, and data about green and blue views from home. Most other studies only have data about the amount of green and blue spaces in general,” he said.

“The strong protective associations of frequency of green space visits make sense to me and indicate the importance of one’s actual nature exposure,” he added. “Like the results of our study, these results provide clinicians with more evidence of the importance of being close to nature and of encouraging patients to take more walks. If they live near a park, that could be a good place to be more physically active and reduce stress levels.”

The study was supported by the Academy of Finland and the Ministry of the Environment. Dr. Turunen and Dr. Klompmaker report no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

High HDL-C levels linked to increased fracture risk
Clinician Reviews
More type 2 diabetes deaths from cancer than heart disease
Clinician Reviews
Novel resuscitation for patients with nonshockable rhythms in cardiac arrest
Clinician Reviews
Angioedema risk jumps when switching HF meds
Clinician Reviews
Elevated PCSK9 levels associated with psoriasis suggest new treatment target
Clinician Reviews
Long QT syndrome overdiagnosis persists
Clinician Reviews
CV deaths jumped in 2020, reflecting pandemic toll
Clinician Reviews
Universal testing for Lp(a): What are we waiting for?
Clinician Reviews
The new blood pressure target in primary care
Clinician Reviews
Legacy ICDs exposed to MRI still shock, pace as needed
Clinician Reviews